(Q51394133)

4 April 2018

title

Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation. (English)

1 reference

4 April 2018

0 references

0 references

1 reference

1 reference

Matsuda Y

1

1 reference

4 April 2018

Kouno S

2

1 reference

4 April 2018

Hiroyama Y

3

1 reference

4 April 2018

Kuraya K

4

1 reference

4 April 2018

Kamitomo M

5

1 reference

4 April 2018

Ibara S

6

1 reference

4 April 2018

Hatae M

7

1 reference

4 April 2018

publication date

1 August 2000

1 reference

4 April 2018

European Journal of Obstetrics Gynecology and Reproductive Biology

published in

1 reference

4 April 2018

volume

91

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

page(s)

159-164

1 reference

4 April 2018

Birthweight specific trends in cerebral palsy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Case-control study of intrapartum care, cerebral palsy, and perinatal death

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

TREATMENT OF ECLAMPSIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Chorioamnionitis and intraamniotic infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Two-year infant neurodevelopmental outcome after expectant management and indicated preterm delivery in hypertensive pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Prenatal and perinatal factors and cerebral palsy in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Association between protective efficacy of antibodies to tumor necrosis factor and suppression of nitric oxide production in neonatal rats with fatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Magnesium sulfate and cerebral palsy in premature infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

Effect of magnesium sulfate treatment on neonatal bone abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900256-0

7 January 2021

10.1016/S0301-2115(99)00256-0

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018